Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)

Digital

Autores:: Ponte-Negretti, Carlos I.
Wyss, Fernando S.
Piskorz, Daniel
Santos, Raul D.
Villar, Raul
Lorenzatti, Alberto
Lopez-Jaramillo, Patricio
Toth, Peter P.
Amaro, A. Juan J.
Rodrigo, Alfonso K.
Lanas, Fernando
Urina-Triana, Miguel
Lara, Jofre
Valdes, Osiris
Gomez-Mancebo, José R.
Bryce, Alfonso
Cobos S., Leonardo
Puente-Barragan, Adriana
Ullauri-Solórzano, Vladimir E.
Medina-Palomino, Felix A.
Lozada, Alfredo F.
Duran, Maritza
Berrospi, Percy
Mirand, David
Badimon, Juan J.
González, J. José R.
Libby, Peter

Tipo de recurso:: Article of journal

Fecha de publicación:: 2022

Institución:: Universidad de Santander

Repositorio:: Repositorio Universidad de Santander

Idioma:: eng

id	RUDES2_f611a495431f752fc22ed67c9e9e60e8
oai_identifier_str	oai:repositorio.udes.edu.co:001/6084
network_acronym_str	RUDES2
network_name_str	Repositorio Universidad de Santander
repository_id_str
dc.title.spa.fl_str_mv	Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)
dc.title.alternative.spa.fl_str_mv	Consenso latinoamericano para el manejo del riesgo residual cardiometabólico. Consenso realizado por la Academia Latinoamericana de Lipidología y Riesgo Cardiometabólico (ALALIP), con el aval de la Sociedad Interamericana de Cardiología (SIAC), la Sociedad Interamericana de Aterosclerosis (IAS) y el Colegio Panamericano de Endotelio (PACE)
title	Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)
spellingShingle	Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE) Residual risk Cardiovascular risk Cardiometabolic risk factors Atherosclerotic cardiovascular disease Inflammation Thrombosis Riesgo residual Riesgo cardiovascular Riesgo cardiometabólico Enfermedad cardiovascular aterosclerótica Inflamación Trombosis
title_short	Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)
title_full	Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)
title_fullStr	Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)
title_full_unstemmed	Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)
title_sort	Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)
dc.creator.fl_str_mv	Ponte-Negretti, Carlos I. Wyss, Fernando S. Piskorz, Daniel Santos, Raul D. Villar, Raul Lorenzatti, Alberto Lopez-Jaramillo, Patricio Toth, Peter P. Amaro, A. Juan J. Rodrigo, Alfonso K. Lanas, Fernando Urina-Triana, Miguel Lara, Jofre Valdes, Osiris Gomez-Mancebo, José R. Bryce, Alfonso Cobos S., Leonardo Puente-Barragan, Adriana Ullauri-Solórzano, Vladimir E. Medina-Palomino, Felix A. Lozada, Alfredo F. Duran, Maritza Berrospi, Percy Mirand, David Badimon, Juan J. González, J. José R. Libby, Peter
dc.contributor.author.none.fl_str_mv	Ponte-Negretti, Carlos I. Wyss, Fernando S. Piskorz, Daniel Santos, Raul D. Villar, Raul Lorenzatti, Alberto Lopez-Jaramillo, Patricio Toth, Peter P. Amaro, A. Juan J. Rodrigo, Alfonso K. Lanas, Fernando Urina-Triana, Miguel Lara, Jofre Valdes, Osiris Gomez-Mancebo, José R. Bryce, Alfonso Cobos S., Leonardo Puente-Barragan, Adriana Ullauri-Solórzano, Vladimir E. Medina-Palomino, Felix A. Lozada, Alfredo F. Duran, Maritza Berrospi, Percy Mirand, David Badimon, Juan J. González, J. José R. Libby, Peter
dc.contributor.researchgroup.spa.fl_str_mv	Masira
dc.subject.proposal.eng.fl_str_mv	Residual risk Cardiovascular risk Cardiometabolic risk factors Atherosclerotic cardiovascular disease Inflammation Thrombosis
topic	Residual risk Cardiovascular risk Cardiometabolic risk factors Atherosclerotic cardiovascular disease Inflammation Thrombosis Riesgo residual Riesgo cardiovascular Riesgo cardiometabólico Enfermedad cardiovascular aterosclerótica Inflamación Trombosis
dc.subject.proposal.spa.fl_str_mv	Riesgo residual Riesgo cardiovascular Riesgo cardiometabólico Enfermedad cardiovascular aterosclerótica Inflamación Trombosis
description	Digital
publishDate	2022
dc.date.accessioned.none.fl_str_mv	2022-02-21T20:24:06Z
dc.date.available.none.fl_str_mv	2022-02-21T20:24:06Z
dc.date.issued.none.fl_str_mv	2022-01-03
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.content.spa.fl_str_mv	Text
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/ART
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.doi.none.fl_str_mv	10.24875/ACM.21000005
dc.identifier.issn.none.fl_str_mv	16651731
dc.identifier.uri.none.fl_str_mv	https://repositorio.udes.edu.co/handle/001/6084
identifier_str_mv	10.24875/ACM.21000005 16651731
url	https://repositorio.udes.edu.co/handle/001/6084
dc.language.iso.spa.fl_str_mv	eng
language	eng
dc.relation.citationendpage.spa.fl_str_mv	112
dc.relation.citationissue.spa.fl_str_mv	1
dc.relation.citationstartpage.spa.fl_str_mv	99
dc.relation.citationvolume.spa.fl_str_mv	92
dc.relation.indexed.spa.fl_str_mv	Scopus
dc.relation.ispartofjournal.spa.fl_str_mv	Archivos de cardiología de México
dc.rights.spa.fl_str_mv	© 2021 The Authors, Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer.
dc.rights.coar.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.creativecommons.spa.fl_str_mv	Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc/4.0/
rights_invalid_str_mv	© 2021 The Authors, Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer. Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) https://creativecommons.org/licenses/by-nc/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.extent.spa.fl_str_mv	14 p
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Archivos de Cardiología de México
dc.publisher.place.spa.fl_str_mv	Mexico
dc.source.spa.fl_str_mv	https://www.archivoscardiologia.com/frame_esp.php?id=372
institution	Universidad de Santander
bitstream.url.fl_str_mv	https://repositorio.udes.edu.co/bitstreams/0cfb2447-1b9d-428b-abca-eea2e0c27944/download https://repositorio.udes.edu.co/bitstreams/59cf4d86-a78f-4263-a2cb-251cb82eac83/download https://repositorio.udes.edu.co/bitstreams/e5a6b50f-f40c-496e-ad60-0fc7122d6636/download https://repositorio.udes.edu.co/bitstreams/da9f1d6d-f2f5-4b6d-b782-9fdddeba842f/download
bitstream.checksum.fl_str_mv	8643d17e0577ff798c3239b64b075bab 38d94cf55aa1bf2dac1a736ac45c881c 5dbe86c1111d64f45ba435df98fdc825 08c9b29748f04eac3640edfe8cd3994c
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5 MD5
repository.name.fl_str_mv	Repositorio Universidad de Santander
repository.mail.fl_str_mv	soporte@metabiblioteca.com
_version_	1814158982675169280
spelling	Ponte-Negretti, Carlos I.aa4fa6a6-ec38-4ec9-b38e-326540920af4-1Wyss, Fernando S.016d89c3-a929-450e-a12d-6065576bae0b-1Piskorz, Daniel2d704970-31b8-4b73-9219-c2ed8029e093-1Santos, Raul D.3dc8158e-69c8-4b0d-be1d-842d33414b22-1Villar, Raul11e23ef6-c20f-4f7b-b3c3-e3abde8893b1-1Lorenzatti, Alberto71e4963d-98ef-4758-842d-3895f421d7d2-1Lopez-Jaramillo, Patricio9a71267b-dcb0-4d31-b37d-2d30be58d4d2-1Toth, Peter P.eba00c8b-d7a8-4ee6-9ab3-35905e6ef412-1Amaro, A. Juan J.043c0274-a31f-470b-92fc-d97be2f188c6-1Rodrigo, Alfonso K.1318fadb-83c6-41f4-8cd3-856c69a6834b-1Lanas, Fernandod22b7fe4-9f1f-4028-a22b-be782ef03d3c-1Urina-Triana, Miguelb826df07-93f5-479b-a0ee-e1f8fd4a1867-1Lara, Jofre64eee3c1-044e-4bff-b1a1-55cb6f616133-1Valdes, Osiris1b384432-f473-4f59-8d59-7d07600c5fff-1Gomez-Mancebo, José R.396ae63a-bfcc-4424-87fa-5a9b47547849-1Bryce, Alfonsoe8e146b7-3177-4ac9-b609-6d0b0c5921dc-1Cobos S., Leonardo8035a655-c357-4ee8-aae1-a3fd8d81771e-1Puente-Barragan, Adriana93710128-19b4-47f8-8479-4025a2b34d00-1Ullauri-Solórzano, Vladimir E.0978795a-203f-47a7-9d09-01131739c69a-1Medina-Palomino, Felix A.46b051fa-3f0e-45a5-880b-1241abc5e6ee-1Lozada, Alfredo F.4842b3f5-389b-4fe1-a85b-76e9dca52d2e-1Duran, Maritza7713b0ea-60eb-4355-9b13-78499b941778-1Berrospi, Percyd098fe7a-7fd7-4ff3-a991-f4b9d8b1b34d-1Mirand, David9da1544d-a7e8-44fd-80c7-fe2e74636837-1Badimon, Juan J.c8daa731-dec6-430a-93c9-1df619b9a135-1González, J. José R.7b510a86-0d29-4522-926a-c75dbf393cdb-1Libby, Peter74295e8c-7250-4fd5-9c32-c5f3e853b09f-1Masira2022-02-21T20:24:06Z2022-02-21T20:24:06Z2022-01-03DigitalBackground: Hypertension, hyperglycemia, dyslipidemia, overweight, obesity, and tobacco (smoking, chewing, and vaping), together with a pro-inflammatory and procoagulant state, are the main risk factors related to atherosclerotic cardiovascular disease. Objective and methods: A group of experts from the Americas, based on their clinical expertise in cardiology, cardiovascular prevention, and cardiometabolic (CM) diseases, joined together to develop these practical recommendations for the optimal evaluation and treatment of residual CM risk factors in Latin America, using a modified Delphi methodology (details in electronic TSI) to generate a comprehensive CM risk reduction guideline, and through personalized medicine and patient-centered decision, considering the cost-benefit ratio The process was well defined to avoid conflicts of interest that could bias the discussion and recommendations. Results: Residual risk reduction should consider therapeutic options adapted to specific patient needs, based on five treatment objectives: triglyceride-rich lipoproteins, inflammation, impaired glucose metabolism, high blood pressure, and prothrombotic status. Comprehensive control of all CM risk factors should be a priority to deal with this important public health problem and prevent premature deaths. The recommendations in this paper address the evidence-based treatment of CM risk and are intended for clinical application in Latin American countries.Antecedentes: Un grupo de factores de riesgo cardiometabólicos (hipertensión, hiperglucemia, dislipidemia, sobrepeso, obesidad y tabaco (fumado, masticado, vaporizado), junto con un estado proinflamatorio y procoagulante, son los principales factores de riesgo relacionados con la enfermedad cardiovascular aterosclerótica. Objetivo y métodos: Basándose en su experiencia en cardiología, prevención cardiovascular y enfermedades cardiometabólicas, un grupo de expertos de las Américas se unió para desarrollar estas recomendaciones prácticas para la evaluación y tratamiento óptimos de los factores de riesgo cardiometabólicos residuales en América Latina, utilizando una metodología Delphi modificada con el objetivo de generar una guía integral de pautas para la reducción del riesgo cardiometabólico, mediante la medicina personalizada y la decisión centrada en el paciente teniendo en cuenta la relación costo-beneficio. El proceso fue bien definido para evitar conflictos de intereses que podrían sesgar la discusión y las recomendaciones. Resultados: La reducción del riesgo residual debe considerar opciones terapéuticas adaptadas a las necesidades específicas del paciente, basadas en 5 objetivos de tratamiento: lipoproteínas ricas en triglicéridos inflamación, metabolismo de la glucosa, presión arterial alta y estado protrombótico. El Control integral de todos los factores de riesgo cardiometabólicos debe ser una prioridad para hacer frente a este importante problema de salud pública y prevenir las muertes prematuras. Las recomendaciones de este documento abordan el tratamiento basado en evidencia del riesgo cardiometabólico y están destinadas a la aplicación clínica en los países de América Latina.Ciencias Médicas y de la Salud14 papplication/pdf10.24875/ACM.2100000516651731https://repositorio.udes.edu.co/handle/001/6084engArchivos de Cardiología de MéxicoMexico11219992ScopusArchivos de cardiología de México© 2021 The Authors, Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer.info:eu-repo/semantics/openAccessAtribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/http://purl.org/coar/access_right/c_abf2https://www.archivoscardiologia.com/frame_esp.php?id=372Residual riskCardiovascular riskCardiometabolic risk factorsAtherosclerotic cardiovascular diseaseInflammationThrombosisRiesgo residualRiesgo cardiovascularRiesgo cardiometabólicoEnfermedad cardiovascular ateroscleróticaInflamaciónTrombosisLatin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)Consenso latinoamericano para el manejo del riesgo residual cardiometabólico. Consenso realizado por la Academia Latinoamericana de Lipidología y Riesgo Cardiometabólico (ALALIP), con el aval de la Sociedad Interamericana de Cardiología (SIAC), la Sociedad Interamericana de Aterosclerosis (IAS) y el Colegio Panamericano de Endotelio (PACE)Artículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85Todas las AudienciasPublicationORIGINALLatin American Consensus on management of residual Cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic.pdfLatin American Consensus on management of residual Cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic.pdfapplication/pdf235835https://repositorio.udes.edu.co/bitstreams/0cfb2447-1b9d-428b-abca-eea2e0c27944/download8643d17e0577ff798c3239b64b075babMD51LICENSElicense.txtlicense.txttext/plain; charset=utf-859https://repositorio.udes.edu.co/bitstreams/59cf4d86-a78f-4263-a2cb-251cb82eac83/download38d94cf55aa1bf2dac1a736ac45c881cMD52TEXTLatin American Consensus on management of residual Cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic.pdf.txtLatin American Consensus on management of residual Cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic.pdf.txtExtracted texttext/plain5https://repositorio.udes.edu.co/bitstreams/e5a6b50f-f40c-496e-ad60-0fc7122d6636/download5dbe86c1111d64f45ba435df98fdc825MD53THUMBNAILLatin American Consensus on management of residual Cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic.pdf.jpgLatin American Consensus on management of residual Cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic.pdf.jpgGenerated Thumbnailimage/jpeg12831https://repositorio.udes.edu.co/bitstreams/da9f1d6d-f2f5-4b6d-b782-9fdddeba842f/download08c9b29748f04eac3640edfe8cd3994cMD54001/6084oai:repositorio.udes.edu.co:001/60842023-10-09 16:51:54.564https://creativecommons.org/licenses/by-nc/4.0/© 2021 The Authors, Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer.https://repositorio.udes.edu.coRepositorio Universidad de Santandersoporte@metabiblioteca.comTGljZW5jaWEgZGUgUHVibGljYWNpw7NuIFVERVMKRGlyZWN0cmljZXMgZGUgVVNPIHkgQUNDRVNPCgo=

Publicaciones similares